SQSTM1 and hepatocellular carcinoma: Although the activation of classical p62-NRF2 signaling increased the expression of SLC7A11 to protect against ferroptosis in hepatocellular carcinoma cells [10], but this theory alone could not explain the opposite effect of p62 on ferroptosis in different p53 mutation status.